Trial
NCT01719861
Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Joel Neal
Collaborators
—
Condition
Small Cell Lung Cancer (SCLC)
Intervention
Desipramine HCL
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-17